生命科学资讯

Thermo Fisher Scientific Launches TSQ Certis Triple Quadrupole Mass Spectrometer to Empower Routine Labs - Lab Manager

Illumina Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily

Illumina Shows Rising Price Performance With Jump To 82 RS Rating - Investor's Business Daily

Thermo Fisher Scientific Stock To $390? - Trefis

Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT In - GuruFocus

Here’s What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings - Yahoo Finance

Assessing Illumina (ILMN) Valuation After Recent Share Price Momentum Shifts - simplywall.st

Spatial Biomarker Panels for Clinical Trials

Generate caps a strong month for biotech IPOs with $400M offering

Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics - The Korea Herald

As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress

'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process

Rift Valley fever virus dynamics in a transhumant cattle system in The Gambia

Genetic network shaping Kenyon cell identity and function in Drosophila mushroom bodies

Agilent Technologies (A) Margin Slippage Challenges Bullish Earnings Improvement Narrative - simplywall.st

Agilent Technologies (A) Margin Slippage Challenges Bullish Earnings Improvement Narrative - simplywall.st

The next generation is shaping the future of rare diseases - Illumina

The Analyst Verdict: Agilent Technologies In The Eyes Of 9 Experts - Benzinga

DOJ urges Supreme Court to undo revival of Hikma ‘skinny label’ case

Doug Ingram’s force of will meets its match as Sarepta CEO plans to depart